High expression of L-type amino acid transporter 1 in infiltrating glioma cells

被引:57
|
作者
Nawashiro H. [1 ]
Otani N. [1 ]
Uozumi Y. [1 ]
Ooigawa H. [1 ]
Toyooka T. [1 ]
Suzuki T. [1 ]
Katoh H. [1 ]
Tsuzuki N. [1 ]
Ohnuki A. [1 ]
Shima K. [1 ]
Shinomiya N. [2 ]
Matsuo H. [3 ]
Kanai Y. [4 ]
机构
[1] Department of Neurosurgery, National Defense Medical College, Tokorozawa, Saitama 359-8513
[2] Department of Microbiology, National Defense Medical College, Saitama
[3] 1st Department of Physiology, National Defense Medical College, Saitama
[4] Department of Pharmacology and Toxicology, Kyorin University, School of Medicine, Tokyo
关键词
Glioma; Immunohistochemistry; LAT1;
D O I
10.1007/s10014-005-0188-z
中图分类号
学科分类号
摘要
L-type amino acid transporter 1 (LAT1), a neutral amino acid transport agent, is essential for the transport of large neutral amino acids. LAT1 also corresponds to tumor-associated gene-1 (TA1), an oncofetal antigen that is expressed primarily in fetal tissues and cancer cells such as glioma cells. We have investigated the expression of the transporter in the human primary glioma tissue from 68 patients. Among these patients, we could see the border zone between tumors and normal bain tissues in 10 patients. By WHO criteria, two of the specimens were diagnosed as grade 2, three as grade 3, and five as grade 4 [glioblastoma multiforme (GBM)]. In 9 of 10 cases, we could identify the infiltrating glioma cells associated with stronger immunoreactivity for LAT1. These tumor cells aggregated around the neurons in the border zone and were often found in the perivascular space. In one GBM case, the tumors seemed to develop expansively and separated from the normal brain with a border of arachnoid membrane. The expression of LAT1 was always higher in infiltrating glioma cells than in cells located in the center of the tumor. These findings suggest that LAT1 is one of the molecular targets for glioma therapy. © 2005 The Japan Society of Brain Tumor Pathology.
引用
收藏
页码:89 / 91
页数:2
相关论文
共 50 条
  • [41] L-type amino acid transporter (LAT) 1 expression in 18F-FET-negative gliomas
    Franziska J. Vettermann
    Caroline Diekmann
    Lorraine Weidner
    Marcus Unterrainer
    Bogdana Suchorska
    Viktoria Ruf
    Mario Dorostkar
    Vera Wenter
    Jochen Herms
    Jörg-Christian Tonn
    Peter Bartenstein
    Markus J. Riemenschneider
    Nathalie L. Albert
    EJNMMI Research, 11
  • [42] Bronchopulmonary dysplasia impairs L-type amino acid transporter-1 expression in human and baboon lung
    Bao, Erik L.
    Chystsiakova, Anastasiya
    Brahmajothi, Mulugu V.
    Sunday, Mary E.
    Pavlisko, Elizabeth N.
    Wempe, Michael F.
    Auten, Richard L.
    PEDIATRIC PULMONOLOGY, 2016, 51 (10) : 1048 - 1056
  • [43] Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer
    K Kaira
    Y Sunose
    K Arakawa
    T Ogawa
    N Sunaga
    K Shimizu
    H Tominaga
    N Oriuchi
    H Itoh
    S Nagamori
    Y Kanai
    A Segawa
    M Furuya
    M Mori
    T Oyama
    I Takeyoshi
    British Journal of Cancer, 2012, 107 : 632 - 638
  • [44] Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer
    Kaira, K.
    Sunose, Y.
    Arakawa, K.
    Ogawa, T.
    Sunaga, N.
    Shimizu, K.
    Tominaga, H.
    Oriuchi, N.
    Itoh, H.
    Nagamori, S.
    Kanai, Y.
    Segawa, A.
    Furuya, M.
    Mori, M.
    Oyama, T.
    Takeyoshi, I.
    BRITISH JOURNAL OF CANCER, 2012, 107 (04) : 632 - 638
  • [45] Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma
    Maimaiti, Maihulan
    Sakamoto, Shinichi
    Yamada, Yasutaka
    Sugiura, Masahiro
    Rii, Junryo
    Takeuchi, Nobuyoshi
    Imamura, Yusuke
    Furihata, Tomomi
    Ando, Keisuke
    Higuchi, Kosuke
    Xu, Minhui
    Sazuka, Tomokazu
    Nakamura, Kazuyoshi
    Kaneda, Atsushi
    Kanai, Yoshikatsu
    Kyprianou, Natasha
    Ikehara, Yuzuru
    Anzai, Naohiko
    Ichikawa, Tomohiko
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [46] L-type amino acid transporter (LAT) 1 expression in 18F-FET-negative gliomas
    Vettermann, Franziska J.
    Diekmann, Caroline
    Weidner, Lorraine
    Unterrainer, Marcus
    Suchorska, Bogdana
    Ruf, Viktoria
    Dorostkar, Mario
    Wenter, Vera
    Herms, Jochen
    Tonn, Jorg-Christian
    Bartenstein, Peter
    Riemenschneider, Markus J.
    Albert, Nathalie L.
    EJNMMI RESEARCH, 2021, 11 (01)
  • [47] Therapeutic Potential for Intractable Asthma by Targeting L-Type Amino Acid Transporter 1
    Hayashi, Keitaro
    Kaminuma, Osamu
    BIOMOLECULES, 2022, 12 (04)
  • [48] l-Type amino acid transporter 1 inhibitors inhibit tumor cell growth
    Oda, Koji
    Hosoda, Noriko
    Endo, Hiroshi
    Saito, Kunio
    Tsujihara, Kenji
    Yamamura, Michio
    Sakata, Takeshi
    Anzai, Naohiko
    Wempe, Michael F.
    Kanai, Yoshikatsu
    Endou, Hitoshi
    CANCER SCIENCE, 2010, 101 (01): : 173 - 179
  • [49] L-type amino acid transporter 1 as a target for inflammatory disease and cancer immunotherapy
    Hayashi, Keitaro
    Anzai, Naohiko
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2022, 148 (01) : 31 - 40
  • [50] Potential Biomarker of L-type Amino Acid Transporter 1 in Breast Cancer Progression
    Liang Z.
    Cho H.T.
    Williams L.
    Zhu A.
    Liang K.
    Huang K.
    Wu H.
    Jiang C.
    Hong S.
    Crowe R.
    Goodman M.M.
    Shim H.
    Nuclear Medicine and Molecular Imaging, 2011, 45 (2) : 93 - 102